European Commission study shows 5% leap in European industrial R&D spending

The 2006 EU Industrial R&D Investment Scoreboard shows that the top 1000 EU companies increased their R&D by an average of 5.3 % in 2005. This figure is in line with the results of a Commission survey released earlier this year. The top 1000 non-EU companies raised their R&D investment by 7.7%, showing a world-wide boost in R&D spending. The EU maintains a high profile, with 18 of the top 50 R&D spenders and 5 of the 10 word-wide companies with the fastest R&D growth. These figures emerge from the analysis of the top 1000 EU and 1000 non-EU companies investing in R&D. The full report, including detailed sector-by-sector analysis will be available later this year.

Janez Potočnik, European Commissioner for Science and Research said "This year's R&D scoreboard is very encouraging. If this trend continues, we could gradually close the R&D investment gap. I hope that at the Lahti summit later this month, European leaders will support the Commission's proposals to go further to boost innovation in Europe, and give even more impetus to these positive developments."

After a period of sluggish R&D growth, this year's scoreboard shows a strong increase in R&D investment worldwide. An average growth rate for EU companies of 5.3% contrasts with last year's growth rate for 0.7% and a contraction of 2% in 2004. The R&D investment growth of companies in the rest of the world in 2005 was 7.7%, one percent higher than the previous year.

The EU companies continue to perform well among the top R&D investors. Of the worldwide top 50, 18 are EU companies, the same number as last year, including 5 of the 10 fastest R&D growth companies worldwide. From the rest of the world, the top 50 includes 18 US companies, 10 Japanese (2 less than last year), 2 Swiss and 2 South Korean (the 2006 Scoreboard reports high R&D growth by South Korean companies). Most of top R&D investors are from automobile & parts sector (13 companies), pharmaceuticals (11 companies) and IT Hardware (9 companies). Daimler-Chrysler is once again the biggest R&D investor among EU companies.

This year, the Scoreboard includes a larger proportion of companies from sectors showing high R&D growth rates, especially in the EU group, where the presence of companies in R&D-intensive sectors such as software & computer services and pharmaceutical & biotechnology has increased.

The EU Industrial R&D Investment Scoreboard is published annually by the European Commission (DG RTD and DG JRC-IPTS) as part of its Industrial Research Investment Monitoring (IRIM) activity. The number of companies in the Scoreboard increased from 1400 last year to 2000 in the present edition. Together, the 1000 companies from the EU and the 1000 from outside invested €371 billion in R&D, estimated to represent more than half of world corporate R&D investment.

Details of all 2000 companies including R&D and financial data and in-depth analysis of the data are available from http://iri.jrc.es. An in-depth analysis of the data will be published before the end of the year.

© European Communities, 2006

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...